PATH-05. A RETROSPECTIVE STUDY OF TREATMENT STRATEGIES AND OUTCOMES IN WHO GRADE II AND III ISOCITRATE DEHYDROGENASE (IDH) WILD-TYPE ASTROCYTOMA

BACKGROUND: WHO grade II and III IDH wild-type astrocytomas behave more aggressively than their IDH mutated counterparts. A subpopulation shares molecular features with the novel entity proposed in cIMPACT-NOW Update 3 “Diffuse astrocytic glioma, IDH wild-type, with molecular features of glioblastom...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Aaroe, Ashley, Dono, Antonio, Youssef, Michael, Alfaro-Munoz, Kristin, Weathers, Shiao-Pei, O’Brien, Barbara, Majd, Nazanin, Harrison, Rebecca, Loghin, Monica, Soomro, Zaid, Williford, Garret, Fuller, Gregory, Yung, W K Alfred, Yeboa, Debra, Esquenazi, Yoshua, Ballester, Leomar Y, de Groot, John, Kamiya-Matsuoka, Carlos
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Molecular Pathology & Classification
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651549/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.687
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares